AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

EBR SYSTEMS INC-CDI

1.220

+0.0352.95%

Volume:819.23K

Turnover:999.35K

Market Cap:454.88M

PE:-6.22

High:1.255

Open:1.180

Low:1.170

Close:1.185

Loading ...

Overview Company News Filings

Market Chatter: Eletrobras Shareholders Approve Deal on Brazil Government Voting Rights

MT Newswires Live

FDA Approves Wise® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (Lvep) Device for Crt

THOMSON REUTERS

FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT

BRIEF-EBR Systems Inc Says CMS Proposes To Approve Wise CRT System

EBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device

MT Newswires Live

EBR Systems Inc - Centers for Medicare & Medicaid Services (CMS) Proposing to Approve Wise Crt System for New Technology Add-on Payment for FY26

THOMSON REUTERS

Which ASX company has just secured FDA approval?

Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device

MT Newswires Live

BRIEF-Ebr Systems Receives FDA Approval For Wise CRT System

EBR Systems Inc - FDA Approval for Wise Crt System

THOMSON REUTERS

EBR Systems (ASX:EBR) Has Debt But No Earnings; Should You Worry?

Simply Wall St.

EBR Systems Says US FDA Approval for Wireless Cardiac Therapy System Nears

MT Newswires Live

Eletrobras Shares Rise After Deal Reached With Brazilian Government Over Voting Rights, Nuclear Plant

MT Newswires Live

BUZZ-Australia's EBR Systems jumps to record high on manufacturing expansion

EBR Systems Secures 11-Year Lease Deal for Commercial Facility; Shares Up 4%

MT Newswires Live

EBR Systems' Wireless Pacing System Gets Accepted into US Reimbursement Pathway; Shares Reach All-Time High

MT Newswires Live

EBR Systems Says US FDA Completes Pre-Approval Inspection; Shares Hit All-Time High

MT Newswires Live

3 ASX All Ords shares leading the charge in 2025

ASX Market Update: Index pares early gains in afternoon trade | January 6, 2025

The Market Herald

EBR Systems Says US FDA Updated Manufacturing Pre-Approval Inspection Schedule; Shares Reach All-Time High

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EBR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EBR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EBR.AU\",,,,,undefined,":{"symbol":"EBR.AU","market":"AU","secType":"STK","nameCN":"EBR SYSTEMS INC-CDI","latestPrice":1.22,"timestamp":1745993520000,"preClose":1.185,"halted":0,"volume":819225,"delay":0,"nameEN":"EBR SYSTEMS INC-CDI","floatShares":277280059,"shares":372851324,"eps":-0.1962664748831319,"marketStatus":"Not Yet Opened","change":0.035,"latestTime":"04-30 16:12:00 AEST","open":1.18,"high":1.255,"low":1.17,"amount":999353,"amplitude":0.07173,"askPrice":1.24,"askSize":6000,"bidPrice":1.205,"bidSize":3750,"shortable":3,"etf":0,"ttmEps":-0.1962664748831319,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":1.185,"openAndCloseTimeList":[[1745971200000,1745992800000]],"volumeRatio":0.727162,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EBR.AU\",,,,,undefined,":{"symbol":"EBR.AU","floatShares":277280059,"roa":"-31.42%","roe":"-147.25%","lyrEps":-0.196266,"volumeRatio":0.727162,"shares":372851324,"dividePrice":0,"high":1.255,"amplitude":0.07173,"preClose":1.185,"low":1.17,"week52Low":0.82,"pbRate":"11.95","week52High":2.08,"institutionHeld":0,"latestPrice":1.22,"committee":-0.230769,"eps":-0.1962664748831319,"divideRate":0,"volume":819225,"delay":0,"ttmEps":-0.1962664748831319,"open":1.18,"prevYearClose":1.025,"prevWeekClose":1.23,"prevMonthClose":1.75,"prevQuarterClose":1.75,"fiveDayClose":1.195,"twentyDayClose":1.79,"sixtyDayClose":1.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EBR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531767810","title":"Market Chatter: Eletrobras Shareholders Approve Deal on Brazil Government Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2531767810","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531767810?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:59","pubTimestamp":1745949560,"startTime":"0","endTime":"0","summary":"Eletrobras (EBR) shareholders have approved a plan to settle a legal fight over the Brazillian government's voting rights in the company, Reuters reported Tuesday.Under the agreement, the government w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","BK7007","EBR.AU","IE00B1B80R65.USD","EBR"],"gpt_icon":0},{"id":"2528748838","title":"FDA Approves Wise® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (Lvep) Device for Crt","url":"https://stock-news.laohu8.com/highlight/detail?id=2528748838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528748838?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:27","pubTimestamp":1744896424,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA1WHYRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBR.AU","BK7007"],"gpt_icon":0},{"id":"2528274805","title":"FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2528274805","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528274805?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:27","pubTimestamp":1744896420,"startTime":"0","endTime":"0","summary":"Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely.\"Recent years have brought significant advancements in leadless pacing for the right heart, but CRT patients were limited to traditional options—until now,\" said principal investigator Niraj Varma, MD, PhD, FRCP, Professor of Medicine at Cleveland Clinic. \"Now, the WiSE System brings a leadless solution to left ventricular pacing, eliminating the biggest limitation of conventional CRT: the lead. This is a game-changer for patients who were previously untreatable due to anatomy or lead failures.\". Patients with challenging anatomy where the LV lead could not be implanted. Patients with high procedural risk for LV lead placement. Backed by Data. Reimagining Delivery of CRT.The SOLVE-CRT trial has delivered promising results for heart failure patients. The WiSE System offers hope to those who have tried other therapies without success and were told no further options existed—until now.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/fda-approves-wise-system-worlds-132700453.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-wise-system-worlds-132700453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CRT","EBR.AU","BK4213","BK7007"],"gpt_icon":0},{"id":"2527917583","title":"BRIEF-EBR Systems Inc Says CMS Proposes To Approve Wise CRT System","url":"https://stock-news.laohu8.com/highlight/detail?id=2527917583","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527917583?lang=en_us&edition=fundamental","pubTime":"2025-04-15 08:20","pubTimestamp":1744676418,"startTime":"0","endTime":"0","summary":"BRIEF-EBR Systems Inc Says CMS Proposes To Approve Wise CRT SystemApril 15  - EBR Systems Inc EBR.AX:CENTERS FOR MEDICARE & MEDICAID SERVICES  PROPOSING TO APPROVE WISE CRT SYSTEM FOR NEW TECHNOLOGY ADD-ON PAYMENT FOR FY26Further company coverage: EBR.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS1YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EBR.AU"],"gpt_icon":0},{"id":"2527173955","title":"EBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2527173955","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527173955?lang=en_us&edition=fundamental","pubTime":"2025-04-15 08:13","pubTimestamp":1744676023,"startTime":"0","endTime":"0","summary":"EBR Systems  said that the US Centers for Medicare & Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.The company plans to seek similar support for outpatient use, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","US5Y.BOND","EBR","US10Y.BOND","US12M.BOND","US6M.BOND","IE00B1B80R65.USD","US7Y.BOND","EBR.AU","US2Y.BOND","US3Y.BOND","US30Y.BOND","BK7007"],"gpt_icon":0},{"id":"2527125797","title":"EBR Systems Inc - Centers for Medicare & Medicaid Services (CMS) Proposing to Approve Wise Crt System for New Technology Add-on Payment for FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2527125797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527125797?lang=en_us&edition=fundamental","pubTime":"2025-04-15 06:29","pubTimestamp":1744669748,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EBR.AU"],"gpt_icon":0},{"id":"2527123886","title":"Which ASX company has just secured FDA approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527123886","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527123886?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:24","pubTimestamp":1744665847,"startTime":"0","endTime":"0","summary":"EBR Systems Inc (ASX: EBR) shares were in the spotlight on Monday when the medical device company released some big news. The ASX company revealed that it has received FDA approval for its WiSE CRT Sy","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/15/which-asx-company-has-just-secured-fda-approval/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4213","EBR.AU","BK7007","CRT"],"gpt_icon":0},{"id":"2527977273","title":"Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2527977273","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527977273?lang=en_us&edition=fundamental","pubTime":"2025-04-14 14:59","pubTimestamp":1744613994,"startTime":"0","endTime":"0","summary":"Australian shares rose on Monday after US President Trump temporarily exempted China from a 125% tariff on popular electronics and introduced flat 10% tariffs on electronics around the globe.The S&P/A","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4213","EBR.AU","BK7007","BK7511","XAO.AU","NEU.AU","IE00B1B80R65.USD","BK7040","CRT","BK7501","BK7508","COL.AU","XJO.AU","BK4081","XKO.AU","WOW.AU","EBR","BK7096","BK7082"],"gpt_icon":0},{"id":"2527945448","title":"BRIEF-Ebr Systems Receives FDA Approval For Wise CRT System","url":"https://stock-news.laohu8.com/highlight/detail?id=2527945448","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527945448?lang=en_us&edition=fundamental","pubTime":"2025-04-14 09:48","pubTimestamp":1744595309,"startTime":"0","endTime":"0","summary":"BRIEF-Ebr Systems Receives FDA Approval For Wise CRT SystemApril 14 (Reuters) - EBR Systems Inc EBR.AX:FDA APPROVAL FOR WISE CRT SYSTEMFurther company coverage: EBR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ033:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EBR.AU"],"gpt_icon":0},{"id":"2527291863","title":"EBR Systems Inc - FDA Approval for Wise Crt System","url":"https://stock-news.laohu8.com/highlight/detail?id=2527291863","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527291863?lang=en_us&edition=fundamental","pubTime":"2025-04-14 06:34","pubTimestamp":1744583656,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250413:nFWN3QQ033:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EBR.AU"],"gpt_icon":0},{"id":"2522393380","title":"EBR Systems (ASX:EBR) Has Debt But No Earnings; Should You Worry?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522393380","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522393380?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:13","pubTimestamp":1743023600,"startTime":"0","endTime":"0","summary":"David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ebr/ebr-systems-shares/news/ebr-systems-asxebr-has-debt-but-no-earnings-should-you-worry","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EBR","EBR.AU"],"gpt_icon":0},{"id":"2522708216","title":"EBR Systems Says US FDA Approval for Wireless Cardiac Therapy System Nears","url":"https://stock-news.laohu8.com/highlight/detail?id=2522708216","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522708216?lang=en_us&edition=fundamental","pubTime":"2025-03-25 07:42","pubTimestamp":1742859731,"startTime":"0","endTime":"0","summary":"EBR Systems  said it expects US Food and Drug Administration  approval for its wireless, cardiac resynchronization therapy system WiSE by April, according to a Tuesday filing with the Australian bourse.Pending regulatory approval, EBR is planning for the commercial launch of the system in the second half of the year, the filing said.Price : $2.05, Change: $+0.075, Percent Change: +3.80%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","EBR","BK7007","IE00B1B80R65.USD","EBR.AU"],"gpt_icon":0},{"id":"2516377764","title":"Eletrobras Shares Rise After Deal Reached With Brazilian Government Over Voting Rights, Nuclear Plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2516377764","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516377764?lang=en_us&edition=fundamental","pubTime":"2025-03-01 02:08","pubTimestamp":1740766089,"startTime":"0","endTime":"0","summary":"Eletrobras  shares were up almost 3% in recent Friday trading after the company said it reached a deal in a mediation process with Brazil's government.The agreement maintains a 10% voting cap on shareholders and would give, among other things, the government the right to appoint three of the 10 members of the company's board, and one of the up to five members of the fiscal council, the company said in a securities filing.Eletrobras said it would present the deal to its shareholders and to Brazil's Federal Supreme Court for approval. Once signed, the company said its investment agreement involving the Angra 3 nuclear power plant will be suspended.The company said it would make no more contributions for the completion of the power plant as a shareholder of Eletronuclear and that the federal government will make efforts to support the divestment of Eletrobras's stake in Eletronuclear should it choose to take that route.Eletrobras also said it would subscribe 2.4 billion Brazilian reais  i","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","IE00B1B80R65.USD","EBR","BK7007","EBR.AU"],"gpt_icon":0},{"id":"2506855732","title":"BUZZ-Australia's EBR Systems jumps to record high on manufacturing expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2506855732","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506855732?lang=en_us&edition=fundamental","pubTime":"2025-01-28 12:24","pubTimestamp":1738038267,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's EBR Systems jumps to record high on manufacturing expansion** Shares of EBR Systems EBR.AX rise as much as 9.8% to a record high of A$1.795; last up 7.7% at A$1.76** Cardiac medical device manufacturer says it has signed an 11-year lease agreement for a new facility in California** Co says the 51,000-square feet facility will provide more space for R&D and manufacturing operations, among others, allowing it to accommodate demand for its wireless cardiac pacing device WiSE** Stock fourth-biggest gainer in the ASX All Ordinaries index .AORD** More than 982,000 shares change hands, 1.6x the 30-day avg** Stock gained 69.3% last year, significantly outperforming the 7.5% gain in AORD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nL3N3OO07G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBR.AU","BK7007"],"gpt_icon":1},{"id":"2506534679","title":"EBR Systems Secures 11-Year Lease Deal for Commercial Facility; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506534679","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506534679?lang=en_us&edition=fundamental","pubTime":"2025-01-28 08:04","pubTimestamp":1738022681,"startTime":"0","endTime":"0","summary":"EBR Systems  secured an 11-year commercial lease agreement for a 51,000 square feet facility in California, expanding its manufacturing capabilities, according to a Monday filing with the Australian bourse.Rent will begin in January 2026 and will be paid on a monthly basis, starting with 20,000 square feet in the first year, 30,000 square feet in the second year, 40,000 square feet in the third year, and 51,136 square feet in the fourth year, and thereafter, the filing said.The company plans to upgrade and qualify the facility, expected to be completed in the first half of 2026, per the filing.Shares rose 4% in morning trade Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EBR.AU","BK4081","EBR","BK7007","IE00B1B80R65.USD"],"gpt_icon":0},{"id":"2504011412","title":"EBR Systems' Wireless Pacing System Gets Accepted into US Reimbursement Pathway; Shares Reach All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2504011412","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504011412?lang=en_us&edition=fundamental","pubTime":"2025-01-20 09:31","pubTimestamp":1737336707,"startTime":"0","endTime":"0","summary":"EBR Systems'  WiSE system was accepted into the Centers for Medicare & Medicaid Services' Transitional Coverage for Emerging Technologies reimbursement pathway, according to a Monday filing with the Australian bourse.WiSE technology is a wireless pacing system designed to stimulate the heart's left ventricle.The pathway is designed to expedite Medicare coverage for a select group of breakthrough devices designated by the US Food and Drug Administration, enabling early access to innovative medical technologies, the filing said.Shares rose nearly 1% in midday trade Monday and earlier reached an all-time high.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B1B80R65.USD","EBR.AU","EBR","BK4081","BK7007"],"gpt_icon":0},{"id":"2504541496","title":"EBR Systems Says US FDA Completes Pre-Approval Inspection; Shares Hit All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2504541496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504541496?lang=en_us&edition=fundamental","pubTime":"2025-01-20 09:01","pubTimestamp":1737334860,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration completed the manufacturing pre-approval inspection of its facilities with no material observations made, according to a Monday filing with the Australian bourse.The company expects regulatory approval by Apr. 13, with commercial launch expected in the second half of the year, the filing said.Shares fell 1% in morning trade Monday but earlier reached an all-time high.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EBR.AU","IE00B1B80R65.USD","BK4081","BK7007","EBR"],"gpt_icon":0},{"id":"2502009293","title":"3 ASX All Ords shares leading the charge in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502009293","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502009293?lang=en_us&edition=fundamental","pubTime":"2025-01-10 10:55","pubTimestamp":1736477701,"startTime":"0","endTime":"0","summary":"Although under pressure today, the All Ordinaries Index is up 1.3% so far in 2025, with three ASX All Ords shares racing ahead of those gains. At market close yesterday, these three companies were leading the charge higher in the nascent new year. You'll also notice a decided trend in the sector they operate in. Which soaring ASX All Ords shares are we talking about?) The EBR Systems share price closed out 2024 at $1.025. In Friday afternoon trade, shares are changing hands for $1.40 apiece. That sees this ASX All Ords stock up 36.6% already in the new year. On Monday, the company, which is developing the world's only wireless cardiac pacing device for heart failure , reported that the US Food and Drug Administration  had scheduled the manufacturing Pre-Approval Inspection  to commence on 14 January. \"This significant","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/10/3-asx-all-ords-shares-leading-the-charge-in-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","XKO.AU","BK7067","PAI.AU","PAI","BK7508","EBR.AU","CYC.AU","IMU.AU","XAO.AU","BK7007"],"gpt_icon":0},{"id":"2501475971","title":"ASX Market Update: Index pares early gains in afternoon trade | January 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501475971","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501475971?lang=en_us&edition=fundamental","pubTime":"2025-01-06 10:37","pubTimestamp":1736131020,"startTime":"0","endTime":"0","summary":"The ASX200 has been down by the smallest of margins at 8,248 points in afternoon trade.Information Technology has been the best performing sector, up 1.25%, followed by Real Estate, up 1.1%, and Energy, up 0.5%.Materials has been the worst performing sector, down 1%, followed by Staples, down 0.25%.EBR Systems has been up more than 2.5% after the US Food and Drug Administration rescheduled the pre-approval inspection of its manufacturing processes.Peninsula Energyhas been down 5.4% on news George Bauk has been appointed managing director and CEO. The structured succession was initiated after outgoing CEO Wayne Heili expressed his intention to step down in 2025.Emerald Resourceshas been up 2.4% on news of a record quarterly gold production at its Okvau Gold Mine in Cambodia.The mine produced 31,888 ounces of gold during the December quarter, surpassing the production guidance of 25,000-30,000 ounces per quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-update-index-pares-early-gains-in-afternoon-trade-january-6-2025-2025-01-06/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7104","BK7007","EBR.AU","PEN.AU","EMR.AU","BK7083"],"gpt_icon":0},{"id":"2501233426","title":"EBR Systems Says US FDA Updated Manufacturing Pre-Approval Inspection Schedule; Shares Reach All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2501233426","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501233426?lang=en_us&edition=fundamental","pubTime":"2025-01-06 09:00","pubTimestamp":1736125252,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration scheduled the manufacturing pre-approval inspection to start Jan. 14, according to a Monday filing with the Australian bourse.The updated schedule does not affect the expected regulatory approval timing, which remains on track for the first quarter of 2025, with commercial launch later in the year, the filing said.The inspection aims to confirm the company's manufacturing procedures are compliant with Quality System regulations and ensure consistent device production, according to the filing.Shares rose nearly 7% in morning trade Monday and earlier reached an all-time high.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IE00B1B80R65.USD","EBR","BK4081","EBR.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EBR.AU\",params:#limit:5,,,undefined,":[{"date":"2024-11-12","symbol":"EBR.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731366000000,"name":null,"time":"Pre-Market","dateTimestamp":1731330000000,"actualEps":null},{"market":"AU","date":"2024-09-20","symbol":"EBR.AU","defaultRemindTime":1726790400000,"type":"split","dateTimestamp":1726754400000,"forFactor":992429,"toFactor":1000000,"ratio":0.992429}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EBR.AU\",market:\"AU\",,,undefined,":[]}}